Idorsia Ltd (OTCMKTS:IDRSF) Short Interest Down 20.0% in December

Idorsia Ltd (OTCMKTS:IDRSF) was the target of a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 7,229,000 shares, a decrease of 20.0% from the November 30th total of 9,037,200 shares. Based on an average daily trading volume, of 10,700 shares, the short-interest ratio is presently 675.6 days.

Idorsia Price Performance

Shares of IDRSF opened at $0.70 on Friday. The firm has a fifty day moving average of $1.12 and a 200-day moving average of $1.99. Idorsia has a 1 year low of $0.70 and a 1 year high of $2.88.

Idorsia Company Profile

Idorsia Ltd, a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for unmet medical needs in Switzerland. The company has a clinical development pipeline that cover various therapeutic areas, including CNS, cardiovascular, and immunological disorders, as well as orphan diseases.